10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001558370-24-008135`
Period End Date	20240331
Filing Date	20240514
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	bpth-20240331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 120 Income Statement 44 Cash Flow Statement 62 Stockholders Equity 26

Balance Sheet 120 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$1.05M	USD	Point-in-time
Cash	`Cash`	$1.05M	USD	Point-in-time
Cash	`Cash`	$188.00K	USD	Point-in-time
Cash	`Cash`	$188.00K	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$632.00K	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$632.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$632.00K	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$632.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$817.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$817.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.36M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.36M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.04M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	398,000.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	398,000.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	753,795.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	753,795.00	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	398,000.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	398,000.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	753,795.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	753,795.00	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.04M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.04M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.07M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.07M	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$76.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$76.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$54.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$54.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$77.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$77.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$102.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$102.00K	USD	Point-in-time
Total Assets	`Assets`	$1.77M	USD	Point-in-time
Total Assets	`Assets`	$1.77M	USD	Point-in-time
Total Assets	`Assets`	$3.22M	USD	Point-in-time
Total Assets	`Assets`	$3.22M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$457.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$457.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.98M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.98M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.35M	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$82.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$82.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$103.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$103.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.81M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.81M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$863.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$863.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$578.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$578.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$3.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.78M	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.78M	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.39M	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.39M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 754 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 754 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 754 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 754 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$108.05M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$108.05M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$108.14M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$108.14M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-110.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-110.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.61M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$441.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$441.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$-2.62M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$-2.62M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.77M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$1.77M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.22M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.22M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.29M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.29M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.99M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.41M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.41M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.30M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.69M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.29M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.29M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-5.29M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-5.29M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.69M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.69M	USD	1 Quarter
Change in fair value of warrant liability	`PeriodChangesInFairValueOfWarrantLiability`	$-538.00K	USD	1 Quarter
Change in fair value of warrant liability	`PeriodChangesInFairValueOfWarrantLiability`	$-538.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$19.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$19.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$19.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$19.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$538.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$538.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-13.25	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-13.25	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-4.88	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-4.88	USD	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	647,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	647,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	398,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	398,000.00	shares	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-4.88	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-4.88	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-13.25	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-13.25	USD	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	398,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	398,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	647,000.00	shares	1 Quarter
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	647,000.00	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.16M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.16M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.27M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.27M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$206.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$206.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$170.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$170.00K	USD	1 Quarter
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$25.00K	USD	1 Quarter
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$25.00K	USD	1 Quarter
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$23.00K	USD	1 Quarter
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$23.00K	USD	1 Quarter
Depreciation	`Depreciation`	$22.00K	USD	1 Quarter
Depreciation	`Depreciation`	$22.00K	USD	1 Quarter
Depreciation	`Depreciation`	$22.00K	USD	1 Quarter
Depreciation	`Depreciation`	$22.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-538.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-538.00K	USD	1 Quarter
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-1.19M	USD	1 Quarter
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-1.19M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-541.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-541.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.93M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.93M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$224.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$224.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-26.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-26.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-28.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-28.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.04M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.04M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.65M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.65M	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$174.00K	USD	1 Quarter
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$174.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$174.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$174.00K	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.65M	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.65M	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-864.00K	USD	1 Quarter
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-864.00K	USD	1 Quarter
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$188.00K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$188.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.73M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$188.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$188.00K	USD	Point-in-time
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$85.00K	USD	1 Quarter
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$85.00K	USD	1 Quarter

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.11M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.11M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$-79.00K	USD	1 Quarter
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$-79.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$206.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$206.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$170.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$170.00K	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-5.27M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-5.27M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Net Income (Loss)	`NetIncomeLoss`	$-3.16M	USD	1 Quarter
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.62M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.11M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.11M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.